GMRE / Global Medical REIT Inc. - SEC-arkivering, Årsberetning, Fuldmagtserklæring

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 2, 2026 (May 28, 2026) Chiro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 2, 2026 (May 28, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

CHIRON REAL ESTATE INC. Articles Supplementary 6.00% Series C Convertible Preferred Stock

Exhibit 3.1 CHIRON REAL ESTATE INC. Articles Supplementary 6.00% Series C Convertible Preferred Stock Chiron Real Estate Inc., a Maryland corporation (the “Corporation”), does hereby certify to the State Department of Assessments and Taxation of Maryland that: FIRST: The charter of the Corporation (the “Charter”) authorizes the issuance of 10,000,000 shares of preferred stock, par value $0.001 per

SEVENTH AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF CHIRON REAL ESTATE LP DESIGNATION OF 6.00% SERIES C CONVERTIBLE PREFERRED UNITS May 28, 2026

Exhibit 10.1 SEVENTH AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF CHIRON REAL ESTATE LP DESIGNATION OF 6.00% SERIES C CONVERTIBLE PREFERRED UNITS May 28, 2026 Pursuant to Sections 4.02 and 11.01 of the Agreement of Limited Partnership of Chiron Real Estate LP (the “Partnership Agreement”), the General Partner hereby amends the Partnership Agreement as follows in connection with the issuanc

Chiron Real Estate Inc. Announces Appointment of Charles Fitzgerald to its Board of Directors and the Declaration of its Second Quarter Preferred Dividends

Exhibit 99.1 Chiron Real Estate Inc. Announces Appointment of Charles Fitzgerald to its Board of Directors and the Declaration of its Second Quarter Preferred Dividends Bethesda, MD – May 20, 2026 – (BUSINESS WIRE) – Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the appointment of Charles Fitzgerald to the Company’s Board of Directors (the “Board”), effective as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 20, 2026 (May 20, 2026) Chiro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 20, 2026 (May 20, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2026 (May 6, 2026) Chiron

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2026 (May 6, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (

INVESTOR RIGHTS AGREEMENT

Exhibit 10.2 Execution Copy [***] = Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. INVESTOR RIGHTS AGREEMENT THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of May 6, 2026, by and among Chiron Real Estate Inc., a Maryland corporation (the “Company”), and the Ho

INVESTMENT AGREEMENT dated as of May 6, 2026 by and among Chiron Real Estate Inc., Maewyn XRN LP TABLE OF CONTENTS

Exhibit 10.1 Execution Copy [***] = Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Certain schedules or similar attachments to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. INVESTMENT AGREEMENT dated as of May 6, 2026 by and among Chiron Real Est

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37815 Chiron Real Estate Inc.

AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT

Exhibit 10.1 AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of March 17, 2026 (this “Amendment No. 1”), is by and among Chiron Real Estate LP (f/k/a Global Medical REIT L.P.), a Delaware limited partnership (the “Borrower”), Chiron Real Estate Inc. (f/k/a Global Medical REIT Inc.), a Maryland corporation

Chiron Real Estate Inc. Enters into Agreements to Acquire $425 Million of SHOP Communities –Inaugural Senior Housing Investments Marks Milestone in Company Growth Plan– –Luxury Communities Located in Premium Submarkets Targeting Affluent Residents–

Exhibit 99.5 Chiron Real Estate Inc. Enters into Agreements to Acquire $425 Million of SHOP Communities –Inaugural Senior Housing Investments Marks Milestone in Company Growth Plan– –Luxury Communities Located in Premium Submarkets Targeting Affluent Residents– Bethesda, MD - May 6, 2026 - (BUSINESS WIRE) - Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced that it ha

Q1 2026 Earnings Supplemental March 31, 2026 3 About Chiron 4 - 5 Quarterly Highlights and Recent Events 6 Consolidated Balance Sheets 7 Consolidated Statements of Operations Reconciliations of Non - GAAP Measures 8 Funds From Operations, Core FFO, a

Exhibit 99.2 Q1 2026 Earnings Supplemental March 31, 2026 3 About Chiron 4 - 5 Quarterly Highlights and Recent Events 6 Consolidated Balance Sheets 7 Consolidated Statements of Operations Reconciliations of Non - GAAP Measures 8 Funds From Operations, Core FFO, and Funds Available for Distribution 9 Net Operating Income, Cash Net Operating Income, and Adjusted EBITDA re 10 Capitalization Summary 1

Positioned for Growth Inaugural SHOP Acquisitions & Strategic Capital Update May 2026

Exhibit 99.3 Positioned for Growth Inaugural SHOP Acquisitions & Strategic Capital Update May 2026 Executive Summary Chiron is repositioning into a growth - oriented healthcare REIT focused on investments that deliver cash flow growth above inflation. This transition centers on disciplined capital allocation and recycling capital into investments with meaningfully higher returns Positioned for Gro

Chiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment led by Maewyn Capital Partners

Exhibit 99.4 Chiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment led by Maewyn Capital Partners Bethesda, MD – May 6, 2026 – (BUSINESS WIRE) – Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the entry into an agreement providing for up to a $100 million delayed-draw convertible perpetual preferred equity invest

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2026 (May 1, 2026) Chiron

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2026 (May 1, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (

Chiron Real Estate Inc. Announces First Quarter 2026 Financial Results –Announces Contracts for Three Seniors Housing Communities for an Aggregate Purchase Price of $425 Million– –Announces $100 Million Strategic Equity Investment from Maewyn Capital

Exhibit 99.1 Chiron Real Estate Inc. Announces First Quarter 2026 Financial Results –Announces Contracts for Three Seniors Housing Communities for an Aggregate Purchase Price of $425 Million– –Announces $100 Million Strategic Equity Investment from Maewyn Capital Partners– –Announces Reduction in Monthly Dividend to Facilitate New Strategic and Growth Plans– Bethesda, MD – May 6, 2026 – (BUSINESS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

ARS

2025 ANNUAL REPORT 6175CHIRON AR 2025FINAL 02.indd 1 6175CHIRON AR 2025FINAL 02.indd 1 4/2/26 4:27 PM 4/2/26 4:27 PMDelivering value at the intersection of care, capital and real estate. 7373 Wisconsin Avenue Suite 800 Bethesda, MD 20814 ChironRE.com 6175CHIRON AR 2025FINAL 02.indd 2 6175CHIRON AR 2025FINAL 02.indd 2 4/2/26 4:27 PM 4/2/26 4:27 PMFellow Shareholders, 2025 was a pivotal year as we d

CHIRON REAL ESTATE INC. UP TO $75,000,000 SHARES OF 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK SALES AGREEMENT

Exhibit 1.2 Execution Version CHIRON REAL ESTATE INC. UP TO $75,000,000 SHARES OF 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK SALES AGREEMENT March 12, 2026 As Agents: A.G.P./ALLIANCE GLOBAL PARTNERS 590 Madison Avenue New York, NY 10022 COLLIERS SECURITIES LLC 90 South 7th Street, Suite 4300 Minneapolis, MN 55402 BMO CAPITAL MARKETS CORP. 151 W 42nd St New York, NY 10036 HUNTINGTON SECUR

FORM OF MASTER FORWARD CONFIRMATION

Exhibit 99.1 FORM OF MASTER FORWARD CONFIRMATION To: Chiron Real Estate Inc. (“Counterparty”) From: [          ] (“Dealer”) [          ] Re: Master Confirmation for Issuer Share Forward Sale Transactions Date: March 12, 2026 Ladies and Gentlemen: The purpose of this communication (this “Master Confirmation”) is to set forth the terms and conditions of the transactions to be entered into from time

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2026 (March 11, 2026) C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2026 (March 11, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporat

CHIRON REAL ESTATE INC. ARTICLES SUPPLEMENTARY 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK

Exhibit 3.1 CHIRON REAL ESTATE INC. ARTICLES SUPPLEMENTARY 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK CHIRON REAL ESTATE INC., a Maryland corporation (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland (the “Department”) that: FIRST: Under a power contained in Article VI of the charter of the Corporation (the “Charter”), the Board of Dire

  CHIRON REAL ESTATE INC. UP TO $300,000,000 SHARES OF COMMON STOCK AMENDED AND RESTATED SALES AGREEMENT

  Exhibit 1.1 Execution Version   CHIRON REAL ESTATE INC.   UP TO $300,000,000 SHARES OF COMMON STOCK AMENDED AND RESTATED SALES AGREEMENT   March 12, 2026 As Agents: A.G.P./ALLIANCE GLOBAL PARTNERS 590 Madison Avenue New York, NY 10022   HUNTINGTON SECURITIES, INC. 41 South High Street Columbus, OH 43215       BMO CAPITAL MARKETS CORP. 151 W 42nd St New York, NY 10036   J.P. MORGAN sECURITIES LLC

SIXTH AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF CHIRON REAL ESTATE LP DESIGNATION OF ADDITIONAL 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED UNITS March 11, 2026

Exhibit 10.1 SIXTH AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF CHIRON REAL ESTATE LP DESIGNATION OF ADDITIONAL 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED UNITS March 11, 2026 Pursuant to Sections 4.02 and 11.01 of the Agreement of Limited Partnership of Chiron Real Estate LP, as amended (the “Partnership Agreement”), the General Partner hereby amends the Partnership Agreement as follo

Up to $288,010,090 Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated April 4, 2024) Up to $288,010,090 Common Stock We and Chiron Real Estate LP have entered into an amended and restated sales agreement, dated March 12, 2026 (the “Sales Agreement”), with BMO Capital Markets Corp., A.G.P./Alliance Global Partners, B. Riley Securities, Inc., Robert W. Baird & Co. I

Up to $75,000,000 8.00% Series B Cumulative Redeemable Preferred Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated April 4, 2024) Up to $75,000,000 8.00% Series B Cumulative Redeemable Preferred Stock We and Chiron Real Estate LP have entered into a sales agreement, dated March 12, 2026 (the “Sales Agreement”), with BMO Capital Markets Corp. A.G.P./Alliance Global Partners, B. Riley Securities, Inc., Robert

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 3, 2026 (March 2, 2026) Chi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 3, 2026 (March 2, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporatio

Chiron Real Estate LP Chiron Real Estate Inc.

  Exhibit 10.1   Execution Version       CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. REDACTED INFORMATION IS INDICATED BY [****].   Chiron Real Estate LP Chiron Real Estate Inc.     Master Note and Guaranty Agreement     Dated as of March 2, 2026            Table of Contents

SUBSIDIARIES OF THE REGISTRANT

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2025: Name State of Organization Chiron Real Estate LP Delaware Chiron Real Estate GP LLC Delaware Inter-American Management LLC Delaware GMR Omaha, LLC Delaware GMR Asheville, LLC Delaware GMR Pittsburgh, LLC Delaware GMR Plano, LLC Delaware GMR Memphis, LLC Delaware GMR Melbourne,

CHIRON REAL ESTATE INC. INSIDER TRADING POLICY

Exhibit 19.1 CHIRON REAL ESTATE INC. INSIDER TRADING POLICY Introduction While performing their duties, the persons identified below as “Covered Persons” may learn material, nonpublic information about Chiron Real Estate Inc. (the “Company”) or another company. This information may be valuable to those who trade in Company shares or the shares of other companies. It is the law, as well as in the i

F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

[Signature Page Follows.]

Exhibit 10.20 Fifth Amendment to the Agreement of Limited Partnership of Chiron Real Estate LP This Amendment, dated February 23, 2026 (this “Amendment”), to the Agreement of Limited Partnership (the “LPA”), of Chiron Real Estate LP (the “Company”) is adopted, executed and agreed to by the General Partner. Capitalized terms not defined in this Amendment are defined in the LPA. WHEREAS, a certifica

Chiron Real Estate Inc. Clawback Policy (this “Policy”)

Exhibit 97.1 Chiron Real Estate Inc. Clawback Policy (this “Policy”) Adopted by the Board of Directors (the “Board”) of Chiron Real Estate Inc. (the “Company”), effective February 23, 2026. This Policy supersedes and replaces all prior and contemporaneous policies of the Company, oral or written, regarding the subject matter contained herein. 1. Recoupment. If the Company is required to prepare a

DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2025, Chiron Real Estate Inc. (the “Company,” “we,”, “our” and “us” refer solely to Chiron Real Estate Inc. and not its subsidiaries) has three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Ex

Q4 2025 Earnings Supplemental December 31, 2025 About Chiron 3 Quarterly Highlights 4 Consolidated Balance Sheets 5 Consolidated Statements of Operations 6 Reconciliations of Non-GAAP Measures Funds From Operations, Core FFO, and Funds Available for

Exhibit 99.2 Q4 2025 Earnings Supplemental December 31, 2025 About Chiron 3 Quarterly Highlights 4 Consolidated Balance Sheets 5 Consolidated Statements of Operations 6 Reconciliations of Non-GAAP Measures Funds From Operations, Core FFO, and Funds Available for Distribution 7 Net Operating Income, Cash Net Operating Income, and Adjusted EBITDAre 8 Capitalization Summary 9 Leverage Statistics and

GLOBAL MEDICAL REIT INC. ARTICLES OF AMENDMENT

Exhibit 3.1 GLOBAL MEDICAL REIT INC. ARTICLES OF AMENDMENT Global Medical REIT Inc., a Maryland corporation (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland that: FIRST: The charter of the Corporation (the “Charter”) is hereby amended to provide that, at the Effective Time (as defined below), the Corporation’s name shall be changed to Chiron Rea

Building For The Future February 2026 Chiron (KAI-ron)—the wisest of all centaurs—was the Greek mythological father of medicine and the original architect of medical education. We aspire to uphold this tradition of stewardship by living our mission o

Exhibit 99.3 Building For The Future February 2026 Chiron (KAI-ron)—the wisest of all centaurs—was the Greek mythological father of medicine and the original architect of medical education. We aspire to uphold this tradition of stewardship by living our mission of delivering value at the intersection of care, capital, and real estate. 2 Our New Identity Portfolio Focused on Essential Care Faciliti

CHIRON REAL ESTATE INC. FIFTH AMENDED AND RESTATED BYLAWS Adopted as of February 23, 2026 Article I

Exhibit 3.2 CHIRON REAL ESTATE INC. FIFTH AMENDED AND RESTATED BYLAWS Adopted as of February 23, 2026 Article I OFFICES Section 1.              PRINCIPAL OFFICE. The principal office of Chiron Real Estate Inc., a Maryland corporation (the “Corporation”), in the State of Maryland shall be located at such place as the board of directors of the Corporation (the “Board of Directors” or “board”) may de

Chiron Real Estate Inc. Announces Fourth Quarter and Full Year 2025 Financial Results –Completes Corporate Rebrand– –Announces 2026 Strategic Objectives & Full Year 2026 Core FFO Guidance– –Announces Change from Quarterly to Monthly Dividends–

Exhibit 99.1 Chiron Real Estate Inc. Announces Fourth Quarter and Full Year 2025 Financial Results –Completes Corporate Rebrand– –Announces 2026 Strategic Objectives & Full Year 2026 Core FFO Guidance– –Announces Change from Quarterly to Monthly Dividends– Bethesda, MD – February 25, 2026 – (BUSINESS WIRE) – Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced financial

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2026 (February 23, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2026 (February 23, 2026) Chiron Real Estate Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 26, 2026 (January 23, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 26, 2026 (January 23, 2026) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 4, 2025 (December 3, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 4, 2025 (December 3, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Number *0* 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK

Exhibit 4.1 Number *0* 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK Global Medical REIT Inc. A CORPORATION FORMED UNDER THE LAWS OF THE STATE OF MARYLAND *0* Shares 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK SEE REVERSE FOR IMPORTANT NOTICE ON TRANSFER RESTRICTIONS AND OTHER INFORMATION CUSIP 37954A402 ISIN US37954A4022 This Certifies that **Specimen** is the record holder of **

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2025 Global Medical

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2025 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Global Medical REIT Inc. (Exact name of regis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 46-4757266 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) 7373 Wiscon

NYSE CERTIFICATION

New York Stock Exchange 11 Wall Street New York, NY 10005 Tel: +1 212.656.3000 nyse.com November 18, 2025 Chief, Information Technology Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE MS 3040 Washington, DC 20549 To whom it may concern: The New York Stock Exchange certifies its approval for listing and registration of the Series B Cumulative Redeemable Preferred S

GLOBAL MEDICAL REIT INC. ARTICLES SUPPLEMENTARY 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK

Exhibit 3.1 GLOBAL MEDICAL REIT INC. ARTICLES SUPPLEMENTARY 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED STOCK Global Medical REIT Inc., a Maryland corporation (the “Company”), hereby certifies to the State Department of Assessments and Taxation of Maryland (the “SDAT”) that: FIRST: The charter of the Company (the “Charter”) authorizes the issuance of 10,000,000 shares of preferred stock, par va

2,000,000 Shares GLOBAL MEDICAL REIT INC. 8.00% Series B Cumulative Redeemable Preferred Stock UNDERWRITING AGREEMENT

Exhibit 1.1 2,000,000 Shares GLOBAL MEDICAL REIT INC. 8.00% Series B Cumulative Redeemable Preferred Stock UNDERWRITING AGREEMENT November 13, 2025 Raymond James & Associates, Inc. BMO Capital Markets Corp. Stifel, Nicolaus & Company, Incorporated Robert W. Baird & Co. Incorporated As Representatives of the Several Underwriters named in Schedule A hereto c/o Raymond James & Associates, Inc. 880 Ca

FOURTH AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF GLOBAL MEDICAL REIT L.P. DESIGNATION OF 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED UNITS November 18, 2025

Exhibit 10.1 FOURTH AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF GLOBAL MEDICAL REIT L.P. DESIGNATION OF 8.00% SERIES B CUMULATIVE REDEEMABLE PREFERRED UNITS November 18, 2025 Pursuant to Sections 4.02 and 11.01 of the Agreement of Limited Partnership of Global Medical REIT L.P. (the “Partnership Agreement”), the General Partner hereby amends the Partnership Agreement as follows in connect

PRICING TERM SHEET 8.00% Series B Cumulative Redeemable Preferred Stock (Liquidation Preference $25.00 per Share) November 13, 2025

Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Relating to Preliminary Prospectus Supplement dated November 13, 2025 to Prospectus dated April 4, 2024 Registration No.

2,000,000 Shares 8.00% Series B Cumulative Redeemable Preferred Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated April 4, 2024) 2,000,000 Shares 8.00% Series B Cumulative Redeemable Preferred Stock Global Medical REIT Inc. (“we,” “us,” “our” or the “Company”) is an internally-managed real estate investment trust (“REIT”) that acquires healthcare facilities and leases those facilities to physician groups an

SUBJECT TO COMPLETION, DATED NOVEMBER 13, 2025

Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securitie

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2025 Global Medical

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2025 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37815 Global Medical REIT Inc.

Global Medical REIT Announces Third Quarter 2025 Financial Results – Amends and Restates Credit Facility– – Completes One-for-Five Reverse Stock Split and Establishes $50 Million Share Repurchase Program–

Exhibit 99.1 Global Medical REIT Announces Third Quarter 2025 Financial Results – Amends and Restates Credit Facility– – Completes One-for-Five Reverse Stock Split and Establishes $50 Million Share Repurchase Program– Bethesda, MD – November 4, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced financial results for the three and nine months e

THIRD QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE St. Joseph’s Medical Plaza – Tucson, AZ

Exhibit 99.2 THIRD QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE St. Joseph’s Medical Plaza – Tucson, AZ Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the sa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2025 (November 4, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2025 (November 4, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Global Medical REIT Inc. Amends and Restates Credit Facility – Extends Loan Maturities and Enters into Forward Starting Interest Rate Swaps to Hedge Term Loans – – Weighted Average Term of the Company’s Debt Increases from 1.3 Years to 4.4 Years –

Exhibit 99.1 Global Medical REIT Inc. Amends and Restates Credit Facility – Extends Loan Maturities and Enters into Forward Starting Interest Rate Swaps to Hedge Term Loans – – Weighted Average Term of the Company’s Debt Increases from 1.3 Years to 4.4 Years – Bethesda, MD – October 8, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that it

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 8, 2025 Global Medical RE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 8, 2025 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commissio

Third Amended and Restated Credit Agreement

  Exhibit 10.1   Execution Version       Third Amended and Restated Credit Agreement   Dated as of October 8, 2025   among   Global Medical Reit L.P., as Borrower   The Guarantors from time to time party hereto,   the Lenders from time to time party hereto,   and   JPMorgan Chase Bank, N.A., as Administrative Agent   BMO Capital Markets Corp. and Wells Fargo Bank, N.A., as Syndication Agents   Cit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 18, 2025 Global Medical

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 18, 2025 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commis

Global Medical REIT Inc. Completes One-for-Five Reverse Stock Split

Exhibit 99.1 September 19, 2025 Global Medical REIT Inc. Completes One-for-Five Reverse Stock Split BETHESDA, Md.-(BUSINESS WIRE)- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) announced today that it has completed the previously announced one-for-five reverse stock split (the “Reverse Stock Split”) of its issued, outstanding and authorized shares of common stock, par value $0.00

GLOBAL MEDICAL REIT INC. ARTICLES OF AMENDMENT

Exhibit 3.1 GLOBAL MEDICAL REIT INC. ARTICLES OF AMENDMENT GLOBAL MEDICAL REIT INC., a Maryland corporation (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland that: FIRST: The Corporation desires to, and does hereby, amend its charter as currently in effect (the “Charter”), pursuant to Section 2-309(e) of the Maryland General Corporation Law (the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2025 (August 5, 2025) G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2025 (August 5, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

SECOND QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston-Salem, NC Forward-Looking Statements Certain statements contained herein may be considered “forward-looking statements” within the meaning of the P

Exhibit 99.2 SECOND QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston-Salem, NC Forward-Looking Statements Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor

Global Medical REIT Announces Second Quarter 2025 Financial Results – Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AF

Exhibit 99.1 Global Medical REIT Announces Second Quarter 2025 Financial Results – Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Bethesda, MD – August 5, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today an

Employment Agreement by and between Mark O. Decker, Jr. and Inter-American Management LLC, effective as of June 23, 2025.

EX-10.1 2 tm2518616d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made and entered into by and between Inter-American Management LLC, a Delaware limited liability company (the “Company”), and Mark Decker (“Employee”), effective as of June 23, 2025 (the “Effective Date”). WHEREAS, the Company desires to employ Employee on the terms and conditi

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 23, 2025 (June 20, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporati

GLOBAL MEDICAL REIT APPOINTS MARK DECKER, JR. AS CEO

EX-99.1 3 tm2518616d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 GLOBAL MEDICAL REIT APPOINTS MARK DECKER, JR. AS CEO Bethesda, MD – June 23, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced that Mark Decker, Jr. has been appointed as the Company’s Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of

GLOBAL MEDICAL REIT INC. BOARD DECLARES 2025 SECOND QUARTER COMMON AND PREFERRED DIVIDENDS

Exhibit 99.2 GLOBAL MEDICAL REIT INC. BOARD DECLARES 2025 SECOND QUARTER COMMON AND PREFERRED DIVIDENDS May 28, 2025 4:05pm EST BETHESDA, Md.-(BUSINESS WIRE)- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2025 (May 28, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

Investor Presentation May 2025

Exhibit 99.1 Investor Presentation May 2025 Our primary mission is to attain earnings growth with a well covered dividend by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus, out - patient medical facilities, and post - acute, in - patient medical facilities; • Asset Yield -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2025 (May 14, 2025) Globa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2025 (May 14, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

FIRST QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of

Exhibit 99.2 FIRST QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe h

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2025 (May 7, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

Global Medical REIT Announces First Quarter 2025 Financial Results – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance –

Exhibit 99.1 Global Medical REIT Announces First Quarter 2025 Financial Results – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Bethesda, MD – May 7, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires

ARS

2024 ANNUAL REPORT POSITIONING GMRE FOR THE FUTURE: STABILITY, STRATEGY & SUCCESSFELLOW STOCKHOLDERS, Nearly 10 years ago, we launched Global Medical REIT (GMRE) as a public company with a strategy focused on owning needs- based healthcare facilities leased to leading healthcare systems and physician groups, with the goal of driving stable cash flows and strong returns for shareholders.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

Global Medical REIT Inc. Insider Trading Policy.

Exhibit 19.1 GLOBAL MEDICAL REIT INC. INSIDER TRADING POLICY Introduction While performing their duties, the persons identified below as “Covered Persons” may learn material, nonpublic information about Global Medical REIT Inc. (the “Company”) or another company. This information may be valuable to those who trade in Company shares or the shares of other companies. It is the law, as well as in the

Subsidiaries of the Company.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2024: Name State of Organization Global Medical REIT L.

F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2025 (February 27, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

Global Medical REIT Announces Fourth Quarter and Full Year 2024 Financial Results – Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Pr

Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Full Year 2024 Financial Results – Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Preferred Dividends – – Announces Full Year 2025 AFFO Guidance – Bethesda, MD – February 27, 2025 – (BUSINESS WIRE) – Global Medical REIT I

FOURTH QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC

Exhibit 99.2 FOURTH QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe

Global Medical REIT Announces Succession Plan Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025.

Exhibit 99.1 Global Medical REIT Announces Succession Plan Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025. Bethesda, MD – January 8, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real esta

Transition and Separation Agreement and General Release of Claims, dated January 8, 2025, by and among Jeffrey Busch, Global Medical REIT Inc., and Inter-American Management LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on January 8, 2025).

  Exhibit 10.1 Execution Version   TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS   This Transition and Separation Agreement and General Release of Claims (this “Agreement”) is entered into as of January 8, 2025 (the “Effective Date”) by and between Jeffrey Busch (“Employee”) and Inter-American Management LLC, a Delaware limited liability company (the “Company”). Global Medical

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 8, 2025 (January 8, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpo

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2024 (November 15, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2024

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2024 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus, out - patient medical facilities, and post - acute, in - patient medi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Global Medical REIT Announces Third Quarter 2024 Financial Results Year-to-Date Completed $80.3 Million in Acquisitions of Single Tenant Triple Net Medical Real Estate

Exhibit 99.1 Global Medical REIT Announces Third Quarter 2024 Financial Results Year-to-Date Completed $80.3 Million in Acquisitions of Single Tenant Triple Net Medical Real Estate Bethesda, MD – November 6, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases

THIRD QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE

Exhibit 99.2 THIRD QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe harbor created thereby . These forwar

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2024 (November 6, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Global Medical REIT Announces Lease with CHRISTUS Health at its Facility in Beaumont, Texas CHRISTUS Health Lease is a triple-net lease with a term of 15 years Former tenant, Steward Health Care, formally requested that its lease be rejected as of Se

Exhibit 99.1 Global Medical REIT Announces Lease with CHRISTUS Health at its Facility in Beaumont, Texas CHRISTUS Health Lease is a triple-net lease with a term of 15 years Former tenant, Steward Health Care, formally requested that its lease be rejected as of September 15, 2024, as part of its Chapter 11 bankruptcy proceedings Bethesda, MD – September 17, 2024 – (BUSINESS WIRE) – Global Medical R

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 17, 2024 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commis

Calculation of Filing Fee Tables

Calculation of Filing Fee Tables S-8 Global Medical REIT Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.001 per share Other 1,650,000 $ 9.15 $ 15,097,500.00 0.0001476 $ 2,228.39 Total O

As filed with the Securities and Exchange Commission on August 12, 2024

As filed with the Securities and Exchange Commission on August 12, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2024 (August 6, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

SECOND QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC

Exhibit 99.2 SECOND QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe

Global Medical REIT Announces Second Quarter 2024 Financial Results Completes $31 million in Acquisitions of Single Tenant Triple Net Medical Real Estate in July

Exhibit 99.1 Global Medical REIT Announces Second Quarter 2024 Financial Results Completes $31 million in Acquisitions of Single Tenant Triple Net Medical Real Estate in July Bethesda, MD – August 6, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those f

LETTER

July 15, 2024 Robert Kiernan Chief Financial Officer Global Medical REIT Inc. 7373 Wisconsin Ave, Suite 800 Bethesda, MD 20814 Re: Global Medical REIT Inc. Form 10-K for the year ended December 31, 2023 Filed on February 28, 2024 File No. 001-37815 Dear Robert Kiernan: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy an

July 3, 2024

July 3, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.

LETTER

United States securities and exchange commission logo June 24, 2024 Robert Kiernan Chief Financial Officer Global Medical REIT Inc.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2024 (May 15, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporati

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2024

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2024 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus, out - patient medical facilities, and post - acute, in - patient medical

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 3, 2024 (June 3, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 16, 2024 (May 15, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2024 (May 7, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

Global Medical REIT Announces First Quarter 2024 Financial Results

Exhibit 99.1 Global Medical REIT Announces First Quarter 2024 Financial Results Bethesda, MD – May 7, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financ

FIRST QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC

Exhibit 99.2 FIRST QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe h

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 5, 2024 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commission

Up to $300,000,000 Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated April 4, 2024) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. previously entered into a sales agreement, dated January 9, 2024 (the “Sales Agreement”), with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

ARS

2023 Annual Report PRUDENT MANAGEMENT. POSITIONED FOR GROWTH. 6024GMR AR202312pFINAL4.indd 1 ɐ30ΖQȴQDQFLDODQGUHDOHVWDWHPDUNHWV QDYLJDWHGDYDULHW\RIFKDOOHQJHVDQG VKLIWLQJ H[SHFWDWLRQV 7KH \HDU EHJDQ ZLWK WKH )HGHUDO 5HVHUYH ODVHUIRFXVHG RQ EULQJLQJ GRZQ LQȵDWLRQ ZLWK FRQWLQXHG LQFUHDVHV LQ LQWHUHVW UDWHV 7KLV IROORZHG E\ FRQFHUQV DERXW UHJLRQDO EDQN IDLOXUHV FRQW

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2024 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commiss

As filed with the Securities and Exchange Commission on February 29, 2024

As filed with the Securities and Exchange Commission on February 29, 2024 Registration No.

Policy Relating to Recovery of Erroneously Awarded Compensation.

Exhibit 97.1 Global Medical REIT Inc. Clawback Policy (this “Policy”) Adopted by the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) on October 18, 2023. This Policy supersedes and replaces all prior and contemporaneous policies of the Company, oral or written, regarding the subject matter contained herein. 1. Recoupment. If the Company is required to prepare a Restate

F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Subsidiaries of the Company.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2023: Name State of Organization Global Medical REIT L.

FOURTH QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC

Exhibit 99.2 FOURTH QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe

As filed with the Securities and Exchange Commission on February 27, 2024

As filed with the Securities and Exchange Commission on February 27, 2024 Registration No.

Up to $300,000,000 Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated February 27, 2024) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. previously entered into a sales agreement, dated January 9, 2024 (the “Sales Agreement”), with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LL

Global Medical REIT Announces Fourth Quarter and Year-End 2023 Financial Results Net Proceeds From 2023 Dispositions Used to Reduce Leverage and Position Company for Growth

Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Year-End 2023 Financial Results Net Proceeds From 2023 Dispositions Used to Reduce Leverage and Position Company for Growth Bethesda, MD – February 27, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare faciliti

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2024 (February 27, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) Global Medical REIT Inc.

GMRE / Global Medical REIT Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01024-globalmedicalreitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Global Medical REIT Inc Title of Class of Securities: Common Stock CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to

GMRE / Global Medical REIT Inc. / BlackRock Inc. Passive Investment

SC 13G/A 1 us37954a2042012524.txt us37954a2042012524.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) Global Medical REIT Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 37954A204 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropria

Calculation of Filing Fee Tables Form S-3 (Form Type) Global Medical REIT Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Global Medical REIT Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common

Sales Agreement, dated January 9, 2024 by and among the Company, Global Medical REIT L.P. and each sales agent, forward seller and forward purchaser

Exhibit 1.1 GLOBAL MEDICAL REIT INC. UP TO $300,000,000 SHARES OF COMMON STOCK SALES AGREEMENT January 9, 2024 As Agents: BMO CAPITAL MARKETS CORP. 151 W 42nd St New York, NY 10036 CITIZENS JMP SECURITIES, LLC 450 Park Avenue, 5th Floor New York, NY 10022 B. RILEY SECURITIES, INC. 299 Park Avenue, 21st Floor New York, NY 10171 J.P. MORGAN sECURITIES LLC 383 Madison Avenue, 6th Floor New York, NY 1

FORM OF MASTER FORWARD CONFIRMATION

Exhibit 99.1   FORM OF MASTER FORWARD CONFIRMATION   To: Global Medical REIT Inc. (“Counterparty”) From: [          ] (“Dealer”) [          ] Re: Master Confirmation for Issuer Share Forward Sale Transactions Date: January [9], 2024   Ladies and Gentlemen:   The purpose of this communication (this “Master Confirmation”) is to set forth the terms and conditions of the transactions to be entered int

Up to $300,000,000 Common Stock

Filed Pursuant to Rule 424(b)(5)  Registration No. 333-276248 PROSPECTUS SUPPLEMENT  (To prospectus dated December 22, 2023) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. have entered into a sales agreement (the “Sales Agreement”) with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, Colliers Securities LLC,

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 9, 2024 (January 9, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorpo

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) Global Medical REIT Inc.

Form of Indenture (for [Subordinated] Debt Securities) (open-ended), incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-3ASR, filed with the SEC on December 22, 2023

Exhibit 4.5 GLOBAL MEDICAL REIT INC. TO , Trustee Indenture (For [Subordinated]* Debt Securities) Dated as of , 20 TABLE OF CONTENTS† Page RECITAL OF THE COMPANY 1 Article I DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.01. Definitions 1 Section 1.02. Compliance Certificates and Opinions 8 Section 1.03. Form of Documents Delivered to Trustee 9 Section 1.04. Acts of Holders 10

As filed with the Securities and Exchange Commission on December 22, 2023

As filed with the Securities and Exchange Commission on December 22, 2023 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 (November 13, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 (November 13, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2023

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2023 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus medical office and post - acute, in - patient medical facilities; • As

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

THIRD QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC

Exhibit 99.2 THIRD QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe h

Global Medical REIT Announces Third Quarter 2023 Financial Results Year-to-Date Completed Three Dispositions Generating Aggregate Gross Proceeds of $80.5 million Resulting in an Aggregate Gain of $15.6 Million

Exhibit 99.1 Global Medical REIT Announces Third Quarter 2023 Financial Results Year-to-Date Completed Three Dispositions Generating Aggregate Gross Proceeds of $80.5 million Resulting in an Aggregate Gain of $15.6 Million Bethesda, MD – November 6, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REI

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2023 (November 6, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Form of LTIP Agreement (Annual Awards).

Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 ANNUAL INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT Annual Award (Performance-Based with Time-Vesting) Name of Grantee: Number of Award LTIP Units: Grant Date: Final Acceptance Date: Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership, dated as of March 14,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 (August 2, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

SECOND QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC

Exhibit 99.2 SECOND QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe

Global Medical REIT Announces Second Quarter 2023 Financial Results Completes Disposition of a Four Property MOB Portfolio Receiving Gross Proceeds of $66 million Resulting in a Gain of $12.8 Million

Exhibit 99.1 Global Medical REIT Announces Second Quarter 2023 Financial Results Completes Disposition of a Four Property MOB Portfolio Receiving Gross Proceeds of $66 million Resulting in a Gain of $12.8 Million Bethesda, MD – August 2, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acqu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2023 (June 6, 2023) Globa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2023 (June 6, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2023 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission a

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2023 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus medical office and post - acute, in - patient medical facilities; • Asset

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2023 (May 15, 2023) Globa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2023 (May 15, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2023

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2023 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in thei

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 (May 10, 2023) Globa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 (May 10, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Form of LTIP Agreement (Long-Term Time-Based Awards).

Exhibit 10.2 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): Final Acceptance Date: Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership, dated as of March 14, 201

Form of LTIP Agreement (Long-Term Performance Awards).

Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership,

Global Medical REIT Announces First Quarter 2023 Financial Results

Exhibit 99.1 Global Medical REIT Announces First Quarter 2023 Financial Results Bethesda, MD – May 3, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 3, 2023 (May 3, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

First Quarter 2023 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC

Exhibit 99.2 First Quarter 2023 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC Table of Contents Table of Contents Company Overview 3 - 5 Select Quarterly Financial Data 6 Business Summary 7 ESG Summary 8 Portfolio Summary 9 - 10 Top 10 Tenants 11 - 13 Debt and Hedging Summary 14 Total Capitalization and Equi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

ARS

2022 Annual Report A DISCIPLINED APPROACH TO DRIVING LONG-TERM VALUE 5916GMR AR202212pFINAL2.

F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Subsidiaries of the Company.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2022: Name State of Organization Global Medical REIT L.

Global Medical REIT Announces Fourth Quarter and Year-End 2022 Financial Results Acquires $149 Million in Medical Real Estate During 2022

Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Year-End 2022 Financial Results Acquires $149 Million in Medical Real Estate During 2022 Bethesda, MD – February 28, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facili

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2023 (February 28, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2023 (February 28, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

Fourth Quarter 2022 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC

Exhibit 99.2 Fourth Quarter 2022 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC Table of Contents Table of Contents Company Overview 3 - 5 Select Quarterly Financial Data 6 Business Summary 7 ESG Summary 8 Acquisitions 9 Portfolio Summary 10 - 11 Top 10 Tenants 12 - 14 Debt and Hedging Summary 15 Total Capita

GMRE / Global Medical REIT Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0989-globalmedicalreitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Global Medical REIT Inc. Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designa

GMRE / Global Medical REIT Inc / BlackRock Inc. Passive Investment

SC 13G/A 1 us37954a2042013123.txt us37954a2042013123.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) Global Medical REIT Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 37954A204 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropria

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 23, 2023 (January 19, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 23, 2023 (January 19, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 7, 2022 (December 7, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Fourth Amended and Restated Bylaws of Global Medical REIT Inc., adopted as of December 7, 2022 (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K as filed with the SEC on December 7, 2022).

Exhibit 3.2 GLOBAL MEDICAL REIT INC. FOURTH AMENDED AND RESTATED BYLAWS Adopted as of December 7, 2022 Article I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of Global Medical REIT Inc., a Maryland corporation (the ?Corporation?), in the State of Maryland shall be located at such place as the board of directors of the Corporation (the ?Board of Directors? or ?board?) may designate. Se

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2022

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2022 (November 14, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended September 30, 2022 or ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to .

Third Quarter 2022 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC

Exhibit 99.2 Third Quarter 2022 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical ? Winston - Salem, NC Atrium Health ? Winston - Salem, NC Table of Contents Table of Contents Company Overview 3 - 5 Select Quarterly Financial Data 6 Business Summary 7 ESG Summary 8 Acquisitions 9 Portfolio Summary 10 - 11 Top 10 Tenants 12 - 14 Debt and Hedging Summary 15 Total Capital

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2022 (November 2, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Global Medical REIT Announces Third Quarter 2022 Financial Results Invests $51 Million in Medical Real Estate During Third Quarter and $149 Million Year-to-Date Adds $150 Million Term Loan to Credit Facility 80% of Overall Indebtedness is Fixed-Rate

Exhibit 99.1 Global Medical REIT Announces Third Quarter 2022 Financial Results Invests $51 Million in Medical Real Estate During Third Quarter and $149 Million Year-to-Date Adds $150 Million Term Loan to Credit Facility 80% of Overall Indebtedness is Fixed-Rate Debt Bethesda, MD ? November 2, 2022 ? (BUSINESS WIRE) ? Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a net-lease med

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2022 (October 3, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended June 30, 2022 or ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to .

Global Medical REIT Announces Second Quarter 2022 Financial Results Invests $74 Million in Medical Real Estate During Second Quarter and $121 Million Year-to-Date, with an additional $50 Million Under Contract Adds $150 Million Delayed-Draw Term Loan

Exhibit 99.1 Global Medical REIT Announces Second Quarter 2022 Financial Results Invests $74 Million in Medical Real Estate During Second Quarter and $121 Million Year-to-Date, with an additional $50 Million Under Contract Adds $150 Million Delayed-Draw Term Loan to Credit Facility Bethesda, MD ? August 3, 2022 ? (BUSINESS WIRE) ? Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a

Second Quarter 2022 Earnings Supplemental Three and Six Months Ended June 30, 2022 www.globalmedicalreit.com NYSE: GMRE

Exhibit 99.2 Second Quarter 2022 Earnings Supplemental Three and Six Months Ended June 30, 2022 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 2Q - 2022| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2022 (August 1, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

Amendment No. 1 to Second Amended and Restated Credit Facility Agreement, dated August 1, 2022, by and among Global Medical REIT L.P., Global Medical REIT Inc., the certain Subsidiaries from time to time party thereto as Guarantors, and JPMorgan Chase Bank, N.A., as administrative agent, and the several banks and financial institutions party thereto as lenders (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on August 3, 2022).

Exhibit 10.1 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT, dated as of August 1, 2022 (this ?Amendment No. 1?), is by and among Global Medical REIT L.P., a Delaware limited partnership (the ?Borrower?), Global Medical REIT Inc., a Maryland corporation (the ?Parent? or ?Global Medical REIT?), the certain Subsidi

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 28, 2022 (June 28, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporati

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in the

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2022 (June 6, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in the

Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 13, 2022 (May 11, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation

NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2022

Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in thei

Form of LTIP Award Agreement (Annual Awards).

? Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 ANNUAL INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT ? Annual Award (Performance-Based with Time-Vesting) ? Name of Grantee: [ ] Number of Award LTIP Units: [ ] Grant Date: February 24, 2022 Final Acceptance Date: [ ], 2022 ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), and the Agreement of

Form of LTIP Award Agreement (Long-Term Time-Based Awards).

Exhibit 10.3 ? GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ? LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) ? ? Name of Grantee: ? Number of LTIP Units: ? Grant Date (Closing Date): February 24, 2022 Final Acceptance Date: , ? ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), and the Agreement of Limited Pa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended March 31, 2022 or ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to .

Form of LTIP Award Agreement (Long-Term Performance Awards).

Exhibit 10.2 ? GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ? LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) ? ? ? ? Name of Grantee: ? ? Number of LTIP Units: ? ? Grant Date (Closing Date): February 24, 2022 Final Acceptance Date: , ? ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?),

First Quarter 2022 Earnings Supplemental Three Months Ended March 31, 2022 www.globalmedicalreit.com NYSE: GMRE

Exhibit 99.2 First Quarter 2022 Earnings Supplemental Three Months Ended March 31, 2022 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 1Q - 2022| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Trea

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2022 (May 4, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

Global Medical REIT Announces First Quarter 2022 Financial Results Invests $24 Million in Medical Real Estate During First Quarter and $54 Million Year-to-Date, with an additional $53 Million Under Contract

Exhibit 99.1 Global Medical REIT Announces First Quarter 2022 Financial Results Invests $24 Million in Medical Real Estate During First Quarter and $54 Million Year-to-Date, with an additional $53 Million Under Contract Bethesda, MD ? May 4, 2022 ? (BUSINESS WIRE) ? Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a net-lease medical office real estate investment trust (REIT) that

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

FORM OF MASTER FORWARD CONFIRMATION

Exhibit 99.1 FORM OF MASTER FORWARD CONFIRMATION To: Global Medical REIT Inc. (?Counterparty?) From: [ ] (?Dealer?) [ ] Re: Master Confirmation for Issuer Share Forward Sale Transactions Date: March [28], 2022 Ladies and Gentlemen: The purpose of this communication (this ?Master Confirmation?) is to set forth the terms and conditions of the transactions to be entered into from time to time (each,

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 29, 2022 (March 28, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorpora

Sales Agreement, dated March 28, 2022 by and among the Company, Global Medical REIT L.P. and each sales agent, forward seller and forward purchaser

Exhibit 1.1 GLOBAL MEDICAL REIT INC. UP TO $300,000,000 SHARES OF COMMON STOCK SALES AGREEMENT March 28, 2022 As Agents: BMO CAPITAL MARKETS CORP. 151 W 42nd St New York, NY 10036 JMP SECURITIES LLC 450 Park Avenue, 5th Floor New York, NY 10022 B. RILEY SECURITIES, INC. 299 Park Avenue, 21st Floor New York, NY 10171 J.P. MORGAN sECURITIES LLC 383 Madison Avenue New York, NY 10179 ROBERT W. BAIRD &

Up to $300,000,000 Common Stock

TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(5) ?Registration No. 333-239043? PROSPECTUS SUPPLEMENT ?(To prospectus dated June 17, 2020) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. have entered into a sales agreement (the ?Sales Agreement?) with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated , Berenberg Capital Markets LLC, Colliers

As filed with the Securities and Exchange Commission on March 2, 2022

As filed with the Securities and Exchange Commission on March 2, 2022 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Global Medical REIT Inc.

Subsidiaries of the Company.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2021: ? Name State of Organization Global Medical REIT L.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Fourth Quarter 2021 Earnings Supplemental Three and Twelve Months Ended December 31, 2021 www.globalmedicalreit.com NYSE: GMRE

Exhibit 99.2 Fourth Quarter 2021 Earnings Supplemental Three and Twelve Months Ended December 31, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 4Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial O

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2022 (February 28, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc

Global Medical REIT Announces Fourth Quarter 2021 Financial Results Invests $196 Million in Medical Real Estate During 2021 (including $189 million of new acquisitions and a revenue-generating $7 million expansion of a current facility)

Exhibit 99.1 Global Medical REIT Announces Fourth Quarter 2021 Financial Results Invests $196 Million in Medical Real Estate During 2021 (including $189 million of new acquisitions and a revenue-generating $7 million expansion of a current facility) Bethesda, MD ? February 28, 2022 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a net-lease medical office real

GMRE / Global Medical REIT Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Global Medical REIT Inc. Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru

GMRE / Global Medical REIT Inc / BlackRock Inc. Passive Investment

us37954a2042020322.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) Global Medical REIT Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 37954A204 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

NIMBLE. TENACIOUS. DISCI P LINED. Investor Presentation November 2021

EX-99.1 2 tm2132385d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NIMBLE. TENACIOUS. DISCI P LINED. Investor Presentation November 2021 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a net - lease medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the fo

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2021 (November 9, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 3, 2021 (November 3, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor

Third Quarter 2021 Earnings Supplemental Three and Nine Months Ended September 30, 2021 www.globalmedicalreit.com NYSE: GMRE

Exhibit 99.2 Third Quarter 2021 Earnings Supplemental Three and Nine Months Ended September 30, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 3Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Off

Global Medical REIT Announces Third Quarter 2021 Financial Results Completes $163 Million of Acquisitions Year-to-Date

EX-99.1 2 tm2131832d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces Third Quarter 2021 Financial Results Completes $163 Million of Acquisitions Year-to-Date Bethesda, MD – November 3, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-built health

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended June 30, 2021 OR ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to .

Second Quarter 2021 Earnings Supplemental Three and Six Months Ended June 30, 2021 www.globalmedicalreit.com NYSE: GMRE

EX-99.2 3 tm2123967d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Second Quarter 2021 Earnings Supplemental Three and Six Months Ended June 30, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 2Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2021 (August 3, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

Global Medical REIT Announces Second Quarter 2021 Financial Results Completes $140 Million of Acquisitions Year-to-Date Raises $51 Million of Common Equity During the Second Quarter and $201 Million Year-to-Date

EX-99.1 2 tm2123967d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces Second Quarter 2021 Financial Results Completes $140 Million of Acquisitions Year-to-Date Raises $51 Million of Common Equity During the Second Quarter and $201 Million Year-to-Date Bethesda, MD – August 3, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease med

Investor Presentation June 2020 June 2021

Exhibit 99.1 Investor Presentation June 2020 June 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ?s (the ?Company?, or ?GMRE?) securities . The information contained in this presentation does not purport to be complete and should not be relied upon

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 8, 2021 (June 8, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended through May 26, 2021) (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K as filed with the SEC on May 28, 2021).

EX-10.1 2 tm2117932d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ARTICLE I DEFINITIONS 1.01. Affiliate “Affiliate” means, with respect to any entity, any other entity, whether now or hereafter existing, which controls, is controlled by, or is under common control with, the first entity (including, but not limited to, joint ventures, limited liability co

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2021 (May 26, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 25, 2021 (May 25, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation

Investor Presentation June 2020 May 2021

Exhibit 99.1 Investor Presentation June 2020 May 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ?s (the ?Company?, or ?GMRE?) securities . The information contained in this presentation does not purport to be complete and should not be relied upon a

Form of LTIP Award Agreement (Long-Term Performance Awards).

Exhibit 10.2 ? GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ? LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) ? ? ? ? ? ? ? Name of Grantee: ? ? ? Number of LTIP Units: ? ? ? Grant Date (Closing Date): March 2, 2021 ? Final Acceptance Date: ? , ? ? ? ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time

Quarterly Report - 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended March 31, 2021 OR ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to .

First Amendment to Employment Agreement, dated January 27, 2021, by and between Inter-American Management LLC and Alfonzo Leon (incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 7, 2021).

Exhibit 10.6 ? Alfonzo Leon 10401 Strathmore Park Court Unit 405 North Bethesda, Maryland 20852 ? January 27, 2021 ? Dear Alfonzo: ? First Amendment to Employment Agreement ? This letter memorializes our mutual agreement to amend the Employment Agreement between you and Inter-American Management LLC dated July 9, 2020 (the ?Employment Agreement?) as set forth below. ? Effective as of January 1, 20

First Amendment to Employment Agreement, dated January 27, 2021, by and between Inter-American Management LLC and Robert Kiernan (incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 7, 2021).

Exhibit 10.5 ? Robert J. Kiernan 6515 Elgin Lane Bethesda, Maryland 20817 ? January 27, 2021 ? Dear Bob: ? First Amendment to Employment Agreement ? This letter memorializes our mutual agreement to amend the Employment Agreement between you and Inter-American Management LLC dated July 9, 2020 (the ?Employment Agreement?) as set forth below. ? Effective as of January 1, 2021 the second sentence of

Form of LTIP Award Agreement (Long-Term Time-Based Awards).

EX-10.3 4 gmre-20210331xex10d3.htm EX-10.3 Exhibit 10.3 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): March 2, 2021 Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the

Form of LTIP Award Agreement (Annual Awards).

Exhibit 10.1 ? GLOBAL MEDICAL REIT INC. 2016 ANNUAL INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT ? Annual Award (Performance-Based with Time-Vesting) ? ? ? Name of Grantee: [ ] Number of Award LTIP Units: [ ] Grant Date: March 2, 2021 Final Acceptance Date: [ ], 2021 ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), and the Agreement of

First Amendment to Employment Agreement, dated January 27, 2021, by and between Inter-American Management LLC and Jeffrey Busch (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 7, 2021).

Exhibit 10.4 ? Jeffrey Busch 4515 Foxhall Crest NW Washington, DC 20007 ? January 27, 2021 ? Dear Jeff: ? First Amendment to Employment Agreement ? This letter memorializes our mutual agreement to amend the Employment Agreement between you and Inter-American Management LLC dated July 9, 2020 (the ?Employment Agreement?) as set forth below. ? Effective as of January 1, 2021 the second sentence of S

First Quarter 2021 Earnings Supplemental Three Months Ended March 31, 2021 www.globalmedicalreit.com NYSE: GMRE

Exhibit 99.2 First Quarter 2021 Earnings Supplemental Three Months Ended March 31, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 1Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Trea

Global Medical REIT Announces First Quarter 2021 Financial Results Raises $150 Million of Common Equity During the First Quarter Completes $101 Million of Acquisitions Year to Date Amends and Restates Credit Facility

EX-99.1 3 tm2115235d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces First Quarter 2021 Financial Results Raises $150 Million of Common Equity During the First Quarter Completes $101 Million of Acquisitions Year to Date Amends and Restates Credit Facility Bethesda, MD – May 5, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease m

Second Amended and Restated Credit Facility Agreement, dated May 3, 2021, by and among Global Medical REIT L.P., Global Medical REIT Inc., the certain Subsidiaries from time to time party thereto as Guarantors, and JPMorgan Chase Bank, N.A., as administrative agent, and the several banks and financial institutions party thereto as lenders (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on May 5, 2021).

Exhibit 10.1 Second Amended and Restated Credit Agreement Dated as of May 3, 2021 among Global Medical REIT L.P., as Borrower the Guarantors from time to time party hereto, the Lenders from time to time party hereto, and JPMorgan Chase Bank, N.A., as Administrative Agent BMO Capital Markets Corp. and Wells Fargo Bank, N.A., as Syndication Agents Citizens Bank, N.A., KeyBank National Association an

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2021 (May 3, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation)

definitive proxy statement on Schedule 14A related to our 2021 annual meeting of stockholders, filed on April 16, 2021;

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 23, 2021 (March 23, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

Investor Presentation June 2020 March 2021

EX-99.1 2 tm2110560d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Presentation June 2020 March 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ’s (the “Company”, or “GMRE”) securities . The information contained in this presentation does not purport

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 17, 2021 (March 16, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora

Underwriting Agreement, dated as of March 16, 2021, by and among Global Medical REIT Inc., Global Medical REIT L.P., J.P. Morgan Securities LLC, BMO Capital Markets Corp., Stifel, Nicolaus & Company, Incorporated, Wells Fargo Securities, LLC and Robert W. Baird & Co. Incorporated, as representatives of the several underwriters named therein

EX-1.1 2 tm2110037d1ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 7,500,000 Shares GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENT March 16, 2021 J.P. Morgan Securities LLC BMO Capital Markets Corp. Stifel, Nicolaus & Company, Incorporated Wells Fargo Securities, LLC Robert W. Baird & Co. Incorporated As Representatives of the Several Underwriters named in Schedule A hereto c/o J.P. Morgan Securi